NANO-X IMAGING LTD (NASDAQ: NNOX), a company focused on transforming preventive healthcare through advanced medical imaging and AI, has announced a securities purchase agreement for a registered direct offering. The deal is expected to generate approximately $8 million in gross proceeds before fees and expenses. The financing involves the sale of 8 million ordinary shares, or prefunded warrants in lieu thereof, along with warrants to purchase up to an additional 8 million ordinary shares. The combined purchase price is set at $1.00 per share and accompanying warrant. The warrants carry an exercise price of $1.15, become exercisable six months after issuance, and expire five years after closing.
The offering is anticipated to close on or about August 7, 2026, subject to customary closing conditions. Nanox plans to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners is serving as the sole placement agent for the transaction. This capital infusion comes at a critical time as Nanox continues to advance its integrated medical imaging platform, which aims to make preventive care more accessible and efficient.
Nanox is building an end-to-end healthcare ecosystem that includes Nanox.ARC, a cost-effective 3D digital tomosynthesis system; Nanox.AI, which provides AI-based algorithms to augment CT imaging interpretation; Nanox.CLOUD, a secure cloud platform for data management and analytics; and Nanox.MARKETPLACE, which, along with USARAD Holdings, offers remote radiology and cardiology services. Additionally, Nanox Health IT delivers RIS, PACS, AI, dictation, and secure infrastructure solutions. By integrating these components, Nanox aims to lower barriers to adoption, improve utilization, and advance preventive care worldwide.
The company's vision is to expand medical imaging beyond traditional hospital settings, offering a seamless solution from scan to interpretation. This funding will support ongoing operations and the commercialization of its technologies. For more details on the offering, the full press release is available at this link. Investors and industry observers will likely view this as a positive signal for Nanox's continued growth and commitment to its mission.
